dihexa clinical trials or human studies or safety Capsules 10mg for Research DIHEXA - Beverly Hills Rejuvenation

In the pivotal 2018 animal study by Neelakantan et al., systemic treat Mechanism of Action 5-Amino-1MQ inhibits NNMT (nicotinamide N-methyltransferase), an enzyme that catalyzes the N-methylation of nicotinamide using S-adenosylmethionine (SAM) as the methyl donor, producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH) as products

Scandinavian J Immunol (1994) 40:6018

This dual mechanism supports investigation of how lipid mobilization and synthesis are regulated within adipocytes

The peptide also does not stimulate IGF-1 production, avoiding the growth-promoting and potentially mitogenic effects associated with IGF-1 elevation

First, preclinical studies establish basic safety and efficacy in laboratory and animal models

In the home setting, IV fluids would be difficult to administer and potentially dangerous